8.49
price up icon1.31%   0.11
pre-market  Pre-mercato:  8.51   0.02   +0.24%
loading
Precedente Chiudi:
$8.38
Aprire:
$8.37
Volume 24 ore:
210.57K
Relative Volume:
0.78
Capitalizzazione di mercato:
$568.63M
Reddito:
$555.06M
Utile/perdita netta:
$-39.48M
Rapporto P/E:
-14.15
EPS:
-0.6
Flusso di cassa netto:
$29.05M
1 W Prestazione:
+5.07%
1M Prestazione:
+7.06%
6M Prestazione:
+18.25%
1 anno Prestazione:
-18.29%
Intervallo 1D:
Value
$8.33
$8.64
Intervallo di 1 settimana:
Value
$8.01
$8.64
Portata 52W:
Value
$5.81
$11.25

Bioventus Inc Stock (BVS) Company Profile

Name
Nome
Bioventus Inc
Name
Telefono
(919) 474-6700
Name
Indirizzo
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
Name
Dipendente
950
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-11
Name
Ultimi documenti SEC
Name
BVS's Discussions on Twitter

Compare BVS vs ABT, SYK, MDT, BSX, EW

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Devices icon
BVS
Bioventus Inc
8.49 561.26M 555.06M -39.48M 29.05M -0.60
Medical Devices icon
ABT
Abbott Laboratories
113.29 195.21B 44.33B 6.48B 6.92B 3.7033
Medical Devices icon
SYK
Stryker Corp
377.32 141.28B 25.12B 3.25B 4.28B 8.3984
Medical Devices icon
MDT
Medtronic Plc
98.49 123.60B 35.48B 4.64B 5.41B 3.5856
Medical Devices icon
BSX
Boston Scientific Corp
76.28 113.14B 20.08B 2.89B 3.82B 1.9391
Medical Devices icon
EW
Edwards Lifesciences Corp
78.98 45.52B 6.07B 1.06B 799.60M 1.8527

Bioventus Inc Stock (BVS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2026-02-09 Iniziato Barrington Research Outperform
2025-07-07 Iniziato Cantor Fitzgerald Overweight
2024-12-17 Aggiornamento JP Morgan Underweight → Neutral
2023-12-07 Aggiornamento Canaccord Genuity Hold → Buy
2023-08-09 Aggiornamento Craig Hallum Hold → Buy
2022-11-22 Downgrade Craig Hallum Buy → Hold
2022-11-09 Downgrade Canaccord Genuity Buy → Hold
2022-11-09 Downgrade JP Morgan Overweight → Underweight
2022-03-15 Iniziato Craig Hallum Buy
2021-11-15 Ripresa Morgan Stanley Overweight
2021-11-10 Ripresa JP Morgan Overweight
2021-07-01 Downgrade Goldman Buy → Neutral
2021-03-08 Iniziato Canaccord Genuity Buy
2021-03-08 Iniziato Goldman Buy
2021-03-08 Iniziato JP Morgan Overweight
2021-03-08 Iniziato Morgan Stanley Overweight
Mostra tutto

Bioventus Inc Borsa (BVS) Ultime notizie

pulisher
01:57 AM

Bioventus (BVS) versus Its Rivals Head-To-Head Comparison - Defense World

01:57 AM
pulisher
01:22 AM

Comparing Bioventus (BVS) & Its Peers - Defense World

01:22 AM
pulisher
Feb 18, 2026

Bioventus (BVS) vs. Its Rivals Head to Head Review - Defense World

Feb 18, 2026
pulisher
Feb 18, 2026

Reviewing Bioventus (BVS) and The Competition - Defense World

Feb 18, 2026
pulisher
Feb 18, 2026

Understanding Momentum Shifts in (BVS) - Stock Traders Daily

Feb 18, 2026
pulisher
Feb 17, 2026

Bioventus (BVS) vs. Its Rivals Head to Head Survey - Defense World

Feb 17, 2026
pulisher
Feb 17, 2026

Bioventus (BVS) & Its Peers Head-To-Head Survey - Defense World

Feb 17, 2026
pulisher
Feb 16, 2026

Barrington Research Initiates Coverage of Bioventus (BVS) with Outperform Recommendation - Nasdaq

Feb 16, 2026
pulisher
Feb 16, 2026

Bioventus (BVS) vs. Its Rivals Financial Analysis - Defense World

Feb 16, 2026
pulisher
Feb 15, 2026

Risks Report: Is Bioventus Inc. a top pick in the sectorEntry Point & Daily Risk Controlled Trade Plans - mfd.ru

Feb 15, 2026
pulisher
Feb 15, 2026

Will Bioventus Inc. stock outperform Nasdaq indexNew Guidance & Fast Exit Strategy with Risk Control - mfd.ru

Feb 15, 2026
pulisher
Feb 15, 2026

Will Bioventus Inc. stock maintain growth storyJuly 2025 Volume & Long-Term Investment Growth Plans - mfd.ru

Feb 15, 2026
pulisher
Feb 14, 2026

Volatility Watch: Is Bioventus Inc. a top pick in the sectorOptions Play & Weekly Setup with ROI Potential - mfd.ru

Feb 14, 2026
pulisher
Feb 13, 2026

Bioventus Inc. (BVS): Investor Outlook on a Potential 79% Upside in the Medical Devices Sector - DirectorsTalk Interviews

Feb 13, 2026
pulisher
Feb 13, 2026

Head-To-Head Review: Bioventus (BVS) vs. Its Rivals - Defense World

Feb 13, 2026
pulisher
Feb 12, 2026

Chipmakers Recap: Is Bioventus Inc attractive for institutional investors2025 Valuation Update & Weekly High Return Stock Forecasts - baoquankhu1.vn

Feb 12, 2026
pulisher
Feb 12, 2026

Recap Report: Is Bioventus Inc currently under institutional pressure2025 Major Catalysts & Technical Buy Zone Confirmations - baoquankhu1.vn

Feb 12, 2026
pulisher
Feb 10, 2026

Bioventus (NASDAQ:BVS) Upgraded at Barrington Research - MarketBeat

Feb 10, 2026
pulisher
Feb 10, 2026

Those who invested in Bioventus (NASDAQ:BVS) three years ago are up 413% - Yahoo Finance

Feb 10, 2026
pulisher
Feb 09, 2026

Bioventus (NYSE:BVS) Shares Gap UpWhat's Next? - MarketBeat

Feb 09, 2026
pulisher
Feb 09, 2026

Bioventus (NASDAQ:BVS) Shares Gap UpHere's What Happened - MarketBeat

Feb 09, 2026
pulisher
Feb 09, 2026

Barrington Initiates Bioventus at Outperform With $13 Price Target - marketscreener.com

Feb 09, 2026
pulisher
Feb 09, 2026

Bioventus (NYSE:BVS) Earns Outperform Rating from Analysts at Barrington Research - MarketBeat

Feb 09, 2026
pulisher
Feb 09, 2026

This Nokia Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Feb 09, 2026
pulisher
Feb 06, 2026

Avoiding Lag: Real-Time Signals in (BVS) Movement - Stock Traders Daily

Feb 06, 2026
pulisher
Feb 06, 2026

Is Bioventus Inc. attractive for institutional investorsJuly 2025 Snapshot & Technical Pattern Based Buy Signals - baoquankhu1.vn

Feb 06, 2026
pulisher
Feb 06, 2026

Bioventus (NASDAQ:BVS) Trading Up 1.4%Here's What Happened - MarketBeat

Feb 06, 2026
pulisher
Feb 06, 2026

Bioventus (NASDAQ:BVS) Trading 1.4% HigherWhat's Next? - MarketBeat

Feb 06, 2026
pulisher
Feb 04, 2026

Anderson Financial Strategies LLC Invests $901,000 in Bioventus Inc. $BVS - MarketBeat

Feb 04, 2026
pulisher
Jan 29, 2026

Aug Selloffs: Will Bioventus Inc benefit from rising consumer demand2025 Support & Resistance & Reliable Intraday Trade Plans - baoquankhu1.vn

Jan 29, 2026
pulisher
Jan 29, 2026

Is Bioventus Inc currently under institutional pressureEarnings Performance Report & Weekly Top Gainers Trade List - baoquankhu1.vn

Jan 29, 2026
pulisher
Jan 26, 2026

Discipline and Rules-Based Execution in BVS Response - Stock Traders Daily

Jan 26, 2026
pulisher
Jan 26, 2026

US Market Recap: What is Bioventus Incs valuation compared to sectorFed Meeting & Weekly Setup with ROI Potential - baoquankhu1.vn

Jan 26, 2026
pulisher
Jan 25, 2026

Entry Recap: Can CNVS maintain sales growthGap Down & Accurate Technical Buy Alerts - baoquankhu1.vn

Jan 25, 2026
pulisher
Jan 22, 2026

Published on: 2026-01-23 16:18:52 - baoquankhu1.vn

Jan 22, 2026
pulisher
Jan 22, 2026

Bioventus (NYSE:BVS) Trading Up 3.8%Still a Buy? - MarketBeat

Jan 22, 2026
pulisher
Jan 17, 2026

Bioventus Details Turnaround Plan, Four Growth Drivers at J.P. Morgan Conference - Defense World

Jan 17, 2026
pulisher
Jan 16, 2026

Bioness $110M Sale Suit Heads to $8.9M Deal - Law360

Jan 16, 2026
pulisher
Jan 15, 2026

Investment Recap: Is Bioventus Inc in a bullish channel2025 Risk Factors & High Conviction Buy Zone Picks - baoquankhu1.vn

Jan 15, 2026
pulisher
Jan 14, 2026

Institutional investors own a significant stake of 36% in Bioventus Inc. (NASDAQ:BVS) - Yahoo Finance

Jan 14, 2026
pulisher
Jan 14, 2026

Bioventus (NASDAQ:BVS) Stock Price Down 0.6%Should You Sell? - MarketBeat

Jan 14, 2026
pulisher
Jan 13, 2026

Market Catalysts: Is Bioventus Inc currently under institutional pressure2025 Winners & Losers & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn

Jan 13, 2026
pulisher
Jan 11, 2026

Trade Recap: Is Bioventus Inc stock gaining market shareProduct Launch & Safe Capital Preservation Plans - Bộ Nội Vụ

Jan 11, 2026
pulisher
Jan 10, 2026

Recent uptick might appease Bioventus Inc. (NASDAQ:BVS) institutional owners after losing 13% over the past year - simplywall.st

Jan 10, 2026
pulisher
Jan 10, 2026

What Wall Street predicts for Bioventus Inc. stock priceShort Setup & Weekly Sector Rotation Insights - ulpravda.ru

Jan 10, 2026
pulisher
Jan 09, 2026

Why Bioventus Inc. stock could rally in 20252025 Short Interest & Accurate Buy Signal Alerts - Улправда

Jan 09, 2026
pulisher
Jan 09, 2026

Will Bioventus Inc. stock deliver consistent dividendsDay Trade & High Accuracy Trade Alerts - Улправда

Jan 09, 2026
pulisher
Jan 08, 2026

Is Bioventus Inc. stock gaining market share2025 Earnings Impact & Breakout Confirmation Trade Signals - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Can Bioventus Inc. stock sustain revenue growthJuly 2025 Spike Watch & Community Consensus Stock Picks - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

How risky is Bioventus Inc. stock nowJuly 2025 Setups & Free Daily Entry Point Trade Alerts - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Will Bioventus Inc. stock return to pre crisis levelsJuly 2025 Opening Moves & High Accuracy Buy Signal Tips - Улправда

Jan 08, 2026

Bioventus Inc Azioni (BVS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
medical_devices ZBH
$98.25
price up icon 1.13%
medical_devices STE
$249.35
price up icon 1.61%
$72.80
price up icon 3.37%
medical_devices PHG
$31.48
price up icon 0.83%
$82.95
price up icon 1.64%
medical_devices EW
$78.98
price up icon 0.68%
Capitalizzazione:     |  Volume (24 ore):